Pharmacy Daily | New auto-injector

A NEW adrenaline auto-injector device ‘Anapen’ is now available for the treatment of severe allergic shock or anaphylaxis. The Anapen® (adrenaline 300μg/ 0.3mL) and the Anapen® Junior (adrenaline 150μg/0.3mL) are the first new devices for the treatment of allergic shocks and anaphylaxis in around 15 years. Due to the fact that Anapen’s mechanism for action differs from the Epipen, a series of educational and training programs have been set up to educate healthcare professionals, carers and patients on how to use the device, with additional literature currently being distributed through schools and childcare centres. Further education, training and action plans are available on the Australasian Society of Clinical Immunology and Allergy website at www.allergy.org.au, and additional electronic training resources for healthcare professionals are available on LINK Pharmaceuticals website at www.ANAlert.com.au.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 06 May 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 May 10